Menu
Recruiting NCT06751979

Probiotic Treatment of Orthodontic Patients

No phase Interventional Dental Plaque Dental Caries

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Probiotic treatment, Placebo.
Who it may be relevant to
Registry conditions: Dental Plaque, Dental Caries. Basic parameters: from 10 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Denmark
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Effect of the Probiotic Strain Streptococcus Salivarius M18 on de Novo Formation and Composition of Dental Biofilm in Orthodontic Patients: A Randomized Double-blind Placebo-controlled Clinical Trial.

Overview

The purpose of this study is to examine the effect of treatment with a lozenge containing the probiotic strain S. salivarius M18 on the formation, composition and virulence of dental plaque and in healthy orthodontic patients, compared to placebo control.

Interventions

  • Dietary supplement Probiotic treatment
    Daily intake of a lozenge containing the probiotic strain S. salivarius M18.
  • Dietary supplement Placebo
    Placebo

Primary outcome measures

  • Planimetric plaque quantification [Time frame: 6 weeks]
Secondary outcome measures (3)
  • Prevalence of S. salivarius [Time frame: Immediately after intervention]
  • Gingivitis [Time frame: Immediately after intervention]
  • Plaque pH [Time frame: Immediately after intervention]

Eligibility criteria

Inclusion criteria

  • Generally healthy males and females ≥ 10 years of age.
  • Able to read and receive a copy of the signed informed consent form.
  • Have at least 20 natural teeth.
  • Have been undergoing orthodontic treatment with fixed orthodontic appliances in the upper and/or lower jaw > 6 months.
  • An average plaque score of > 2 according to the Modified Orthodontic Plaque Index (MOPI) at the screening appointment.

Exclusion criteria

  • Significant oral soft tissue pathology based on a visual examination.
  • History of allergy or significant adverse events following use of oral hygiene products such as toothpastes, mouth rinses, breath mints, lozenges, or chewing gum or their ingredients.
  • History of allergies to milk proteins.
  • History of allergies towards probiotics.
  • Self-reported as pregnant or nursing.
  • Self-reported serious medical conditions.
  • Antibiotic or anti-inflammatory medication within 30 days of screening visit.
  • Acute sinusitis or severe oral-pharyngeal infections.
  • Smoker.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Triple blind
Primary purpose
Prevention

Study locations

Denmark · 1 center
  • Aarhus University, Department of Dentistry and Oral Health — Aarhus

Identifiers

NCT: NCT06751979 · 1-10-72-77-24

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗